Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents
Launched by SEATTLE CHILDREN'S HOSPITAL · Jun 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new program called the Technology-Enhanced Gender Support (TEGS) platform, designed to help parents and caregivers of gender diverse youth aged 8 to 17. The goal is to see how well this platform works and if parents find it helpful. Participants will start by filling out an online survey, then they will get access to the TEGS platform and will complete follow-up surveys one month and three months later. They will also have the option to share their thoughts in an interview at the end of the study.
To participate, you must be a parent of a gender diverse child between the ages of 8 and 17, have access to the internet, and be able to read or speak English. The study is not yet recruiting participants, but it's essential to know that this research is focused on understanding how technology can better support families in navigating gender diversity. If you meet the criteria and are interested in being part of this important study, keep an eye out for when recruitment begins!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent of a gender diverse youth aged 8-17
- • Has access to the internet
- • Can speak or read English
- Exclusion Criteria:
- • Not a parent of a gender diverse youth aged 8-17
- • No access to the internet
- • Cannot speak or read in English
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported